Phospho-sulindac (OXT-922) inhibits the growth of human colon cancer cell lines: a redox/polyamine-dependent effect

Non-steroidal anti-inflammatory drugs such as sulindac are promising chemoprevention agents against colon cancer, but their weak potency and side effects limit their use for both chemoprevention and chemotherapy. Here, we evaluated the effect of a new sulindac derivative, phospho-sulindac or OXT-922...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Huang, Liqun, Zhu, Caihua, Sun, Yu, Xie, Gang, Mackenzie, Gerardo G., Qiao, George, Komninou, Despina, Rigas, Basil
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2010
Konular:
Cancer Prevention
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2966552/
https://ncbi.nlm.nih.gov/pubmed/20627873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgq149
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller